Five and Ten-Year Outcomes of Neoadjuvant Chemotherapy and Surgery for High-Risk Upper Tract Urothelial Carcinoma.

MLA

Adibi, Mehrad, et al. “Five and Ten-Year Outcomes of Neoadjuvant Chemotherapy and Surgery for High-Risk Upper Tract Urothelial Carcinoma.” Clinical Genitourinary Cancer, vol. 20, no. 2, Apr. 2022, pp. 176–82. EBSCOhost, https://doi.org/10.1016/j.clgc.2021.12.014.

APA

Adibi, M., McCormick, B., Economides, M. P., Petros, F., Xiao, L., Guo, C., Shah, A., Kamat, A. M., Dinney, C., Navai, N., Gao, J., Siefker-Radtke, A., Matin, S. F., & Campbell, M. T. (2022). Five and Ten-Year Outcomes of Neoadjuvant Chemotherapy and Surgery for High-Risk Upper Tract Urothelial Carcinoma. Clinical Genitourinary Cancer, 20(2), 176–182. https://doi.org/10.1016/j.clgc.2021.12.014

Chicago

Adibi, Mehrad, Barrett McCormick, Minas P Economides, Firas Petros, Lianchun Xiao, Charles Guo, Amishi Shah, et al. 2022. “Five and Ten-Year Outcomes of Neoadjuvant Chemotherapy and Surgery for High-Risk Upper Tract Urothelial Carcinoma.” Clinical Genitourinary Cancer 20 (2): 176–82. doi:10.1016/j.clgc.2021.12.014.